ArticleBritish journal of cancer2014

Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy.

M E Pisanu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.